From: Clinical validity of outcome pain measures in naturally occurring canine osteoarthritis
Comparison of PVFBW with: | n | D0 (95% CI) | D30 (95% CI) | D90 (95% CI) | Difference D0D30 (95% CI) | Difference D30D90 (95% CI) |
---|---|---|---|---|---|---|
Primary endpoints | Â | Â | Â | Â | Â | Â |
CSOM | 23 | -.03 (−.64, .32) | .10 (−.38, .57) | -.37 (−.74, .12) | .13 (−.44, .66) | -.71 (−.91, -.34) |
EDA | 23 | -.23 (−.61, .24) | .10 (−.44, .60) | .16 (−.36, .62) | -.12 (−.60, .43) | .31 (−.23, .69) |
Exploratory endpoints | Â | Â | Â | Â | Â | Â |
MA | 7 | -.46 (−1.0, .77) | .10 (−1.0, 1.0) | .45 (−.68, 1.0) | -.04 (−.94, 1.0) | .14 (−1.0, 0.80) |
Ctg(1) | 20 | -.20 (−.65, .42) | -.29 (−.66, .21) | -.13 (−.58, .40) | -.03 (−.67, .74) | -.64 (−.87, -.15) |
Ctg(2) | 10 | .01 (−.77, .78) | .00 (−.77, .79) | -.75 (−1.0, 0.00) | -.03 (−.81, .74) | -.52 (−.90, .45) |
Ctg(3) | 9 | .56 (−.72, 1.0) | .54 (−.31, 1.0) | .52 (−.81, 1.0) | .00 (−.91, .92) | -.99 (−1.0, -.87) |
Ctg(4) | 8 | .20 (−.44, .94) | .09 (−.91, 1.0) | .07 (−.91, 1.0) | .20 (−.94, 1.0) | -.66 (−1.0, .71) |